Literature DB >> 3094962

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

P J Maddon, A G Dalgleish, J S McDougal, P R Clapham, R A Weiss, R Axel.   

Abstract

The isolation of clones encoding the human surface protein T4, and the expression of the T4 gene in new cellular environments, have enabled us to examine the role of this protein in the pathogenesis of AIDS. Our studies support a mechanism of AIDS virus infection that initially involves the specific interaction of the AIDS virus with T4 molecules on the cell surface. This association can be demonstrated on T4+ transformed T and B lymphocytes as well as epithelial cells. Furthermore, the presence of T4 on the surface of all human cells examined is sufficient to render these cells susceptible to AIDS virus infection. Our data suggest that the T4-AIDS virus complex is then internalized by receptor-mediated endocytosis. Finally, we find that the T4 gene is expressed in the brain as well as in lymphoid cells, providing an explanation for the dual neurotropic and lymphotropic character of the AIDS virus. In this manner, a T lymphocyte surface protein important in mediating effector cell-target cell interactions has been exploited by a human retrovirus to specifically target the AIDS virus to populations of T4+ cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094962     DOI: 10.1016/0092-8674(86)90590-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  703 in total

1.  Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Authors:  D Schenten; L Marcon; G B Karlsson; C Parolin; T Kodama; N Gerard; J Sodroski
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.

Authors:  S Mañes; G del Real; R A Lacalle; P Lucas; C Gómez-Moutón; S Sánchez-Palomino; R Delgado; J Alcamí; E Mira; C Martínez-A
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

3.  Modulation of HIV-1 replication by a novel RhoA effector activity.

Authors:  L Wang; H Zhang; P A Solski; M J Hart; C J Der; L Su
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

4.  Soluble receptor-induced retroviral infection of receptor-deficient cells.

Authors:  R Damico; P Bates
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.

Authors:  R Damico; L Rong; P Bates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 6.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

7.  Using viral species specificity to define a critical protein/RNA interaction surface.

Authors:  G A Coburn; H L Wiegand; Y Kang; D N Ho; M M Georgiadis; B R Cullen
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

8.  Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.

Authors:  N Genois; B Barbeau; M Olivier; M J Tremblay
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

9.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

10.  Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.

Authors:  Johnna M Frierson; Andrea J Pruijssers; Jennifer L Konopka; Dirk M Reiter; Ty W Abel; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.